Form 4: Rocket Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

John Militello, a Vice President at Rocket Pharmaceuticals, sold 1,079 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).

Summary

• On May 16, 2024, John Militello, a Vice President at Rocket Pharmaceuticals, sold 1,079 shares of the company's common stock.
• The sale was executed at a price of $23.35 per share.
• The purpose of the sale was to cover tax withholding obligations associated with the vesting of RSUs.
• Following the transaction, Militello directly owns 53,327 shares of Rocket Pharmaceuticals' common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations, which is a common practice.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors for signals about a company's prospects.

Stakeholder Impact

• The sale has a minimal impact on shareholders as it's a small transaction by an individual officer to cover tax obligations.

Key Dates